scispace - formally typeset
D

Doris F. Cully

Researcher at Merck & Co.

Publications -  53
Citations -  6536

Doris F. Cully is an academic researcher from Merck & Co.. The author has contributed to research in topics: Chloride channel & Avermectin. The author has an hindex of 25, co-authored 53 publications receiving 6214 citations. Previous affiliations of Doris F. Cully include Merial & Netherlands Cancer Institute.

Papers
More filters
Journal ArticleDOI

Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans

TL;DR: The electrophysiological and structural properties of these proteins indicate that they are new members of the ligand-gated ion channel superfamily.
Journal ArticleDOI

Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties.

TL;DR: Platencin shows potent in vivo efficacy without any observed toxicity, emphasizing the fact that more antibiotics with novel structures and new modes of action can be discovered by using this antisense differential sensitivity whole-cell screening paradigm.
Journal ArticleDOI

Identification of a Drosophila melanogaster Glutamate-gated Chloride Channel Sensitive to the Antiparasitic Agent Avermectin

TL;DR: The pharmacological data support the hypothesis that the DrosGluCl-α channel represents the arthropod H-receptor and an important target for the avermectin class of insecticides.